Swiftmerge Acquisition Corp. — Q3 2022 Form 10-Q
Entity note: The request identifies Aleanna, Inc., but the filing is for Swiftmerge Acquisition Corp., a Cayman Islands blank-check company. This summary follows the filing.
Business context and reporting period
The unaudited quarter ended September 30, 2022; the filing was signed November 9, 2022. Swiftmerge had not begun operations and was searching for a business combination. It reported no operating revenue. Its 18-month deadline to complete a business combination was June 17, 2023, unless extended.
Key financial metrics
| Metric | Period / date | Amount |
|---|---|---|
| Net income | Three months ended September 30, 2022 | $392,370 |
| Net loss | Nine months ended September 30, 2022 | $96,607 |
| Formation and operating costs | Three months / nine months ended September 30, 2022 | $218,553 / $1,000,286 |
| Trust investment gain | Three months / nine months ended September 30, 2022 | $610,923 / $933,679 |
| Cash outside Trust Account | September 30, 2022 | $531,075 |
| Trust Account investments | September 30, 2022 | $228,184,160 |
| Total liabilities | September 30, 2022 | $8,556,337, including $7,875,000 deferred underwriting fees |
| Operating cash flow | Nine months ended September 30, 2022 | $(344,756) |
| Investing / financing cash flow | Nine months ended September 30, 2022 | $(25,250,000) / $25,250,000 |
The company has no operating revenue or reported margins, and no long-term debt. Class A shares subject to possible redemption were carried at $228.1 million, or $10.14 per share. The Trust Account is reserved principally for a business combination or shareholder redemptions, rather than ordinary operating expenses.
Changes versus comparable periods
- Q3 2022 reported net income of $392,370, versus neither income nor loss in Q3 2021. The Q3 gain primarily reflected Trust Account investment income.
- For the first nine months of 2022, the company reported a $96,607 net loss, compared with a $6,728 loss from inception through September 30, 2021; the periods are not directly comparable.
- Cash outside the Trust Account fell from $875,831 at December 31, 2021 to $531,075 at September 30, 2022. Trust investments rose from $202.0 million to $228.2 million, reflecting the over-allotment proceeds and investment income.
- The company sold 2.5 million additional units in January 2022, raising $25 million, and issued 750,000 additional private placement warrants. Its Class B shares declined by 125,000 to 5.625 million.
Outlook, risks, and unusual items
- Going concern: Management said its cash forecast showed funds outside the Trust Account would not cover operating and liquidity needs through June 17, 2023. The filing states substantial doubt exists about the company’s ability to continue as a going concern. Potential sponsor or insider loans are not committed.
- Business-combination deadline: If no transaction is completed and the deadline is not extended, Swiftmerge must liquidate and redeem public shares; warrants could expire worthless. The filing does not identify a completed transaction or provide financial guidance.
- Controls: Disclosure controls were deemed ineffective because of a material weakness involving recording an unbilled third-party service-provider amount during preparation of the 2021 Form 10-K. Management said it performed additional analysis for this filing.
- Other risks: The filing discusses uncertainty from COVID-19, the war in Ukraine and related sanctions, proposed SEC SPAC rules, and the potential effect of the Inflation Reduction Act’s 1% excise tax on certain share repurchases or redemptions after 2022.
- Unusual items: Nine-month results included a $933,679 Trust Account gain and a $30,000 loss on sale of private placement warrants. The filing reports no legal proceedings or off-balance-sheet arrangements.
Most important facts for investors to verify
- Confirm the correct issuer: the supplied filing is Swiftmerge Acquisition Corp., not Aleanna, Inc.
- Resolve the filing’s inconsistent working-capital figures: $404,431 in the financial-statement note and MD&A, versus $388,981 in the risk-factor disclosure.
- Verify the status of any business-combination discussions, extension plans, and financing sources; the filing reports no committed additional financing.
- Clarify deferred underwriting fees: the notes describe $7.875 million as payable upon a completed business combination, while the MD&A says the underwriter waived rights to those fees upon completion.
- Assess remediation of the disclosed material weakness and monitor the company’s remaining cash runway and June 17, 2023 deadline.